Literature DB >> 32387665

Field cancerization: Definition, epidemiology, risk factors, and outcomes.

Tyler J Willenbrink1, Emily S Ruiz2, Christine M Cornejo2, Chrysalyne D Schmults2, Sarah T Arron3, Anokhi Jambusaria-Pahlajani4.   

Abstract

Field cancerization was first described in 1953 when pathologic atypia was identified in clinically normal tissue surrounding oropharyngeal carcinomas. The discovery of mutated fields surrounding primary tumors raised the question of whether the development of subsequent tumors within the field represented recurrences or additional primary tumors. Since this initial study, field cancerization has been applied to numerous other epithelial tissues, including the skin. Cutaneous field cancerization occurs in areas exposed to chronic ultraviolet radiation, which leads to clonal proliferations of p53-mutated fields and is characterized by multifocal actinic keratoses, squamous cell carcinomas in situ, and cutaneous squamous cell carcinomas. In the first article in this continuing medical education series, we define field cancerization, review the available grading systems, and discuss the epidemiology, risk factors, and outcomes associated with this disease.
Copyright © 2020 American Academy of Dermatology, Inc. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  NOTCH; NOTCH1; TP53; actinic damage; actinic keratoses; actinic keratosis; cutaneous oncology; cutaneous squamous cell carcinoma; field cancerization; field change; field damage; field therapy; immunosuppression; keratinocyte carcinoma; p-53 clonal fields; p53; squamous cell carcinoma

Mesh:

Year:  2020        PMID: 32387665     DOI: 10.1016/j.jaad.2020.03.126

Source DB:  PubMed          Journal:  J Am Acad Dermatol        ISSN: 0190-9622            Impact factor:   11.527


  8 in total

Review 1.  Increasing cancer permeability by photodynamic priming: from microenvironment to mechanotransduction signaling.

Authors:  Nazareth Milagros Carigga Gutierrez; Núria Pujol-Solé; Qendresa Arifi; Jean-Luc Coll; Tristan le Clainche; Mans Broekgaarden
Journal:  Cancer Metastasis Rev       Date:  2022-09-26       Impact factor: 9.237

2.  MicroRNA31 and MMP-1 contribute to the differentiated pathway of invasion -with enhanced epithelial-to-mesenchymal transition- in squamous cell carcinoma of the skin.

Authors:  M T Fernández-Figueras; C Carrato; X Saenz-Sardà; E Musulén; M J Fuente; L Puig
Journal:  Arch Dermatol Res       Date:  2021-10-13       Impact factor: 3.033

Review 3.  A Review of Existing Therapies for Actinic Keratosis: Current Status and Future Directions.

Authors:  Laura Del Regno; Silvia Catapano; Alessandro Di Stefani; Simone Cappilli; Ketty Peris
Journal:  Am J Clin Dermatol       Date:  2022-02-19       Impact factor: 6.233

4.  Repetitive Daylight Photodynamic Therapy versus Cryosurgery for Prevention of Actinic Keratoses in Photodamaged Facial Skin: A Prospective, Randomized Controlled Multicentre Two-armed Study.

Authors:  Sigrid Karrer; Rolf-Markus Szeimies; Wolfgang G Philipp-Dormston; Peter A Gerber; Welf Prager; Elisabeth Datz; Florian Zeman; Karolina Müller; Michael Koller
Journal:  Acta Derm Venereol       Date:  2021-01-04       Impact factor: 3.875

5.  Management Pearls on the Treatment of Actinic Keratoses and Field Cancerization.

Authors:  Jaime Piquero-Casals; Daniel Morgado-Carrasco; Yolanda Gilaberte; Rubén Del Rio; Antonio Macaya-Pascual; Corinne Granger; José Luis López-Estebaranz
Journal:  Dermatol Ther (Heidelb)       Date:  2020-07-17

6.  AKASI and Near-Infrared Spectroscopy in the combined effectiveness evaluation of an actinic keratoses preventive product in immunocompetent and immunocompromised patients.

Authors:  Federica Veronese; Silvia Seoni; Vanessa Tarantino; Matteo Buttafava; Chiara Airoldi; Kristen M Meiburger; Elisa Zavattaro; Paola Savoia
Journal:  Front Med (Lausanne)       Date:  2022-09-07

7.  TP53 Targeted Deep Sequencing of Cell-Free DNA in Esophageal Squamous Cell Carcinoma Using Low-Quality Serum: Concordance with Tumor Mutation.

Authors:  Dariush Nasrollahzadeh; Gholamreza Roshandel; Tiffany Myriam Delhomme; Patrice Hodonou Avogbe; Matthieu Foll; Farrokh Saidi; Hossein Poustchi; Masoud Sotoudeh; Reza Malekzadeh; Paul Brennan; James Mckay; Pierre Hainaut; Behnoush Abedi-Ardekani
Journal:  Int J Mol Sci       Date:  2021-05-26       Impact factor: 5.923

Review 8.  Precision Medicine Gains Momentum: Novel 3D Models and Stem Cell-Based Approaches in Head and Neck Cancer.

Authors:  Annette Affolter; Anne Lammert; Johann Kern; Claudia Scherl; Nicole Rotter
Journal:  Front Cell Dev Biol       Date:  2021-07-08
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.